22.06.2017 - NMI TT Pharmaservices and Charité awarded grant for development of multiplex protein profiling for individualization of tumor therapy
Berlin/Germany, June 22, 2017 – Contract research provider NMI TT Pharmaservices and Charité Universitätsmedizin Berlin today announced that they have been awarded a research grant for development of a multiplex protein profiling based platform that
mehr
24.5.2017 - High-Tech Gründerfonds (HTGF) investiert in SIGNATOPE GmbH aus Reutlingen
Sichere Medikamente durch neue Testverfahren
mehr
18th International EAU17 Meeting - London
2. Preis für Poster in der Kategorie Onkologie für die Arbeitsgruppe Tumorbiologie
mehr
09.03.2017 - Posterpreis für Nicola Groll
DGPT-Preis für das beste Poster
mehr
25.11.2016 - Pluriomics User Meeting
The NMI is sending their expert on MEA technologies to Leiden: Udo Kraushaar has wide experience in this field and will point out the advantages as well as the challenges of the MEA technologies.
mehr